| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Hawkins Richard J serves as a Director at SVRA and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 5 buys and 3 sells. Those positions are worth an estimated $23K at current prices.
Historically, Hawkins Richard J's trades have earned a below-average insider score of 27/100 across 6 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -74.1%.
The biggest single holding is PSTV (~$23K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 15,188 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | SVRA Savara Inc | Director | Buy | 48,225 | $2.04 | $98,571.90 | +71.7% | +74.8% | - | |
| Dec 16, 2024 | SVRA Savara Inc | Director | Sell | 8,000 | $3.32 | $26,568.80 | -10.6% | -13.8% | +97.2% | |
| Sep 13, 2024 | PSTV Plus Therapeutics, Inc. | Director | Buy | 4,000 | $1.50 | $5,996.00 | +35.8% | -10.1% | -69.8% | |
| Sep 12, 2024 | PSTV Plus Therapeutics, Inc. | Director | Buy | 6,285 | $1.35 | $8,511.78 | +128.2% | -5.6% | -68.7% | |
| May 8, 2024 | PSTV Plus Therapeutics, Inc. | Director | Buy | 4,902 | $2.04 | $10,000.08 | +490,200% | -29.5% | -72.7% | |
| Mar 3, 2023 | PSTV Plus Therapeutics, Inc. | Director | Buy | 1 | $1,000.00 | $1,000.00 | New | -25.1% | -61.9% | |
| May 15, 2019 | SVRA Savara Inc | Director | Sale+OE | 25,000 | $11.10 | $277,621.77 | - | - | - |